ESTRO 2024 - Abstract Book

S1085

Clinical - Gynaecology

ESTRO 2024

2. Macchia G, Jereczek-Fossa BA, Lazzari R, et al Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD) International Journal of Gynecologic Cancer 2022;32:939-943. 3. Macchia G, Lazzari R, Colombo N, Laliscia C, Capelli G, D'Agostino GR, Deodato F, Maranzano E, Ippolito E, Ronchi S, Paiar F, Scorsetti M, Cilla S, Ingargiola R, Huscher A, Cerrotta AM, Fodor A, Vicenzi L, Russo D, Borghesi S, Perrucci E, Pignata S, Aristei C, Morganti AG, Scambia G, Valentini V, Jereczek-Fossa BA, Ferrandina G. A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups. Oncologist. 2020 Feb;25(2):e311-e320. doi: 10.1634/theoncologist.2019-0309. Epub 2019 Oct 10. PMID: 32043791; PMCID: PMC7011643. 4. Lazzari R, Ronchi S, Gandini S, Surgo A, Volpe S, Piperno G, Comi S, Pansini F, Fodor C, Orecchia R, Tomao F, Parma G, Colombo N, Jereczek-Fossa BA. Stereotactic Body Radiation Therapy for Oligometastatic Ovarian Cancer: A Step Toward a Drug Holiday. Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):650-660. doi: 10.1016/j.ijrobp.2018.03.058. Epub 2018 Apr 4. PMID: 29893277. 5. Smile TD, Reddy CA, Qiao-Guan G, Winter WI, Stephans KL, Woody NM, Balagamwala EH, Amarnath SR, Magnelli A, AlHilli MM, Michener CM, Mahdi H, DeBernardo RL, Rose PG, Cherian SS. Stereotactic body radiotherapy for the treatment of oligometastatic gynecological malignancy in the abdomen and pelvis: A single institution experience. J Radiosurg SBRT. 2021;7(3):189-197. PMID: 33898082; PMCID: PMC8055243.

2446

Digital Poster

Relapse in Endometrial Cancer: impact of salvage treatment and patients characteristics

M. Ujué Ruiz 1 , Erkuden Burillo 1 , Libe Amondarain 1 , Darwin Enrique Pozo 1 , Carmen Zubeldía 2 , Ignacio Visus 1 , Marta Barrado 1 , Amaya Sola 1 , Sara López 1 , Marisa Fernández 1 , Juan Carlos Muruzabal 3 , Sara Aguirre 3 , Sonia Lapeña 3 , Orencio Tarrío 3 , Nadia Veiga 3 , Naiara Fuentemilla 4 , Santiago Pellejero 4 , Mikel Rico 1 , Elena Villafranca 1 , Enrique Martinez 1 1 Universitary Hospital of Navarra, Radiation Oncology, Pamplona, Spain. 2 Universitary Hospital of Navarra, Oncology Nursing, Pamplona, Spain. 3 Universitary Hospital of Navarra, Gynecologist, Pamplona, Spain. 4 Universitary Hospital of Navarra, Medical Physics, Pamplona, Spain

Purpose/Objective:

Management of relapsed endometrial cancer brings a challenge in radiation oncologist clinical practice. We analyzed a series of patients with recurrent endometrial cancer, describing pathological and molecular factors and the impact of salvage treatments.

Material/Methods:

We performed a retrospective analysis of patients with relapsed endometrial cancer previously treated with curative intent. All patients underwent surgery with hysterectomy and bilateral salpingo-oophorectomy with or